Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722173 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Challenges for a Maturing Biotechnology Industry: Evolve or Perish
Decision Resources, Inc., Aug 2007, Pages: 23


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

Today’s biotech industry is maturing and must now change the way it operates. The industry is facing significant challenges from operational, business, clinical development, and market risks. Business fundamentals, which many biotech companies have had the luxury to ignore, are now emerging as critical elements for sustainability and survival.

Get the Answers You Need to Shape Your Strategy

- Today’s biotech market is increasingly crowded and competitive. What can companies do to differentiate their products? What business fundamentals do they need to understand in order to plan a successful market strategy for their new products?
- Many successful biotech companies are surrendering their independence and merging with larger entities. What made these companies decide to give up their independence? Why have so many of them struggled even after launching blockbuster drugs?
- In the rush to develop a marketed product, many biotech companies are deficit spending. How do some companies manage to make deficit spending pay off? What makes others eventually collapse?
- Many biotechs have licensed away so many of the rights to their first products that they do not reap substantial financial rewards once the products launch. Which companies have made this mistake? Why did they make deals that left them financially vulnerable?

Scope

- Challenges facing the industry: operational, business, clinical development, and market risks.
- Business fundamentals: essential information biotechs need to run their business in today’s market.
- Deficit spending: case studies of how several biotechs handled deficit spending.
- Competing against crowded pipelines: effective strategies, case studies.
- Projections for the future: our projections on what the future holds for the biotech industry and its synergistic relationship with the pharmaceutical industry.


Customers who bought this item also bought

Animal Biotechnology - Technologies, Markets and Companies

Indian Biotechnology Industry Report

Biotechnology in India

Agricultural Biotechnology - Global Strategic Business Report

Global Biotechnology Markets Trends

Global Top 10 Biotechnology Companies — Industry, Financial and SWOT Analysis

The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles

Global Pharmaceuticals, Biotechnology & Life Sciences

The North America Biotechnology Sectors : A Company and Industry Analysis (August 2007)

The Europe Biotechnology Sectors : A Company and Industry Analysis (October 2007)

Modern Biotechnology : Connecting Innovations in Microbiology and Biochemistry to Engineering Fundamentals

Biotechnology Reagents - Global Strategic Business Report



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds